These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 29802388)

  • 21. Single-cell multiregion dissection of Alzheimer's disease.
    Mathys H; Boix CA; Akay LA; Xia Z; Davila-Velderrain J; Ng AP; Jiang X; Abdelhady G; Galani K; Mantero J; Band N; James BT; Babu S; Galiana-Melendez F; Louderback K; Prokopenko D; Tanzi RE; Bennett DA; Tsai LH; Kellis M
    Nature; 2024 Aug; 632(8026):858-868. PubMed ID: 39048816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noggin rescues age-related stem cell loss in the brain of senescent mice with neurodegenerative pathology.
    Díaz-Moreno M; Armenteros T; Gradari S; Hortigüela R; García-Corzo L; Fontán-Lozano Á; Trejo JL; Mira H
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11625-11630. PubMed ID: 30352848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
    Chance SA; Clover L; Cousijn H; Currah L; Pettingill R; Esiri MM
    Cereb Cortex; 2011 Aug; 21(8):1870-8. PubMed ID: 21239393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-exploring the core genes and modules in the human frontal cortex during chronological aging: insights from network-based analysis of transcriptomic studies.
    Xu M; Liu Y; Huang Y; Wang J; Yan J; Zhang L; Zhang C
    Aging (Albany NY); 2018 Oct; 10(10):2816-2831. PubMed ID: 30341976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging.
    Fjell AM; Amlien IK; Westlye LT; Stenset V; Fladby T; Skinningsrud A; Eilsertsen DE; Bjørnerud A; Walhovd KB
    Neuroimage; 2010 Jan; 49(2):1820-30. PubMed ID: 19800012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.
    Huang H; Nie S; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Age (Dordr); 2016 Aug; 38(4):303-322. PubMed ID: 27439903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects.
    Ciavardelli D; Piras F; Consalvo A; Rossi C; Zucchelli M; Di Ilio C; Frazzini V; Caltagirone C; Spalletta G; Sensi SL
    Neurobiol Aging; 2016 Jul; 43():1-12. PubMed ID: 27255810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
    Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
    Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease.
    Soldan A; Pettigrew C; Albert M
    Psychiatr Clin North Am; 2018 Mar; 41(1):65-77. PubMed ID: 29412849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.